Fulgent Genetics Inc reports results for the quarter ended in September - Earnings Summary

Fulgent Genetics

10/11/2021 11:33

* Fulgent Genetics Inc  FLGT.OQ  reported quarterly adjusted
earnings of $3.95​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for earnings of $3.25 per share.
* Revenue rose 124% to $227.87 million from a year ago; 
analysts expected $264.00 million. 
* Fulgent Genetics Inc's reported EPS for the quarter was
$3.93​.
* The mean earnings estimate of analysts had risen by
about 101.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Fulgent Genetics Inc shares had fallen by 12.6% this
quarter and gained 50.9% so far this year.
* The company reported quarterly net income of $122.52 million.
* Wall Street's median 12-month price target for Fulgent
Genetics Inc is $141.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 11:33 a.m.
 ​All figures in US dollars unless otherwise stated